Advisorshares Psychedeli... Share Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 22,045
Bid Price
Ask Price
News -
Day High 4.6499


52 Week Range


Day Low 4.411
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Etf Ticker Symbol Market Type
Advisorshares Psychedelics ETF PSIL AMEX Exchange Traded Fund
  Price Change Change Percent Etf Price Last Traded
0.00 0.0% 4.58 19:56:14
Open Price Low Price High Price Close Price Prev Close
4.58 4.411 4.6499 4.58 4.58
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
212 22,045  4.51  99,412 - 4.30 - 10.70
Last Trade Time Type Quantity Etf Price Currency
20:00:00 100  4.58 USD


Draw Mode:

Advisorshares Psychedelics ETF Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 6.41M 1.40M 1.40M  -  - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Advisorshares Psychedeli...

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

PSIL Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.055.054.304.7433,309-0.47-9.31%
1 Month5.906.25994.305.2430,683-1.32-22.37%
3 Months9.9210.704.307.1034,615-5.34-53.83%
6 Months10.1010.704.307.7830,345-5.52-54.65%
1 Year10.1010.704.307.7830,345-5.52-54.65%
3 Years10.1010.704.307.7830,345-5.52-54.65%
5 Years10.1010.704.307.7830,345-5.52-54.65%

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220129 03:57:42